Letter to the Editor of European Urology Journal Regarding PI-RADS

Current Release
Access PI-RADSTo expedite the transfer of high-quality MRI from laboratories to patients to help improve early diagnosis of clinically significant prostate cancer and reduce unnecessary biopsies and treatment for benign and subclinical diseases. PI-RADS 2.0 and 2.1 are joint developments between the ACR, ESUR and Admetech Foundation.
Further reading:
- PI-RADS Atlas
- PI-RADS v2.1 Report Template: TXT file | PDF file
The PI-RADS AI paper is ready
Requirements for AI Development and Reporting for MRI Prostate Cancer Detection in Biopsy-Naive Men: PI-RADS Steering Committee, Version 1.0
Related Resources
PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway
Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2
ACR Stakeholder Prostate Summit
Develop interpretive skills by reviewing prostate mpMRI cases with pathology correlation and a workshop on MR-guided biopsy.
Earn CME review and analyze the most challenging prostate cases and learn from world-class radiologists.
PI-RADS Archive
PI-RADS v2 Module
Request Permission for PI-RADS
License Information
PI-RADS 2.0 and 2.1 are jointly developed by the American College of Radiology (ACR), European Society of Urogenital Radiology (ESUR) and AdMeTech Foundation. ACR, ESUR and AdMeTech should be acknowledged when referencing PIRADS v2.0 and v2.1. Permissions beyond the scope of reproducing verbatim content publication may be requested by permission form, or contact us: rads@acr.org.